Cargando…

The relevance of somatostatin receptors in thyroid neoplasia.

111In-octreotide scintigraphy in patients with persistent medullary thyroid carcinoma (MTC) visualized tumors in about half of the surgically explored sites. Tumor visualization correlated with rapid tumor growth and large tumor volume as judged from calcitonin levels. The 111In concentration ratio...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ahlman, H., Tisell, L. E., Wängberg, B., Fjälling, M., Forssell-Aronsson, E., Kölby, L., Nilsson, O.
Formato:	Texto
Lenguaje:	English
Publicado:	Yale Journal of Biology and Medicine 1997
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2589271/ https://www.ncbi.nlm.nih.gov/pubmed/9825479

Ejemplares similares

Expression of somatostatin receptors in oncocytic (Hürthle cell) neoplasia of the thyroid
por: Tisell, L E, et al.
Publicado: (1999)

Somatostatin receptors on neuroendocrine tumors--a way to intraoperative diagnosis and localization.
por: Ahlman, H., et al.
Publicado: (1994)

Intraoperative detection of somatostatin-receptor-positive neuroendocrine tumours using indium-111-labelled DTPA-D-Phe1-octreotide.
por: Wangberg, B., et al.
Publicado: (1996)

Uptake of meta-iodobenzylguanidine in neuroendocrine tumours is mediated by vesicular monoamine transporters
por: Kölby, L, et al.
Publicado: (2003)

Successful receptor-mediated radiation therapy of xenografted human midgut carcinoid tumour
por: Kölby, L, et al.
Publicado: (2005)

Comparative studies on the expression of somatostatin receptor subtypes, outcome of octreotide scintigraphy and response to octreotide treatment in patients with carcinoid tumours.
por: Nilsson, O., et al.
Publicado: (1998)

The effect of a somatostatin analogue on the release of hormones from human midgut carcinoid tumour cells.
por: Wängberg, B., et al.
Publicado: (1991)

Histamine metabolism of gastric carcinoids in Mastomys natalensis.
por: Kölby, L., et al.
Publicado: (1998)

Comparison of survival between malignant neuroendocrine tumours of midgut and pancreatic origin
por: Johanson, V, et al.
Publicado: (1999)

Use of a somatostatin analogue in association with surgery and hepatic arterial embolisation in the treatment of the carcinoid syndrome.
por: Ahlman, H., et al.
Publicado: (1987)

Estimation of absorbed dose to the kidneys in patients after treatment with (177)Lu-octreotate: comparison between methods based on planar scintigraphy
por: Larsson, Maria, et al.
Publicado: (2012)

The Ki67 index a prognostic marker in medullary thyroid carcinoma
por: Tisell, L E, et al.
Publicado: (2003)

Praomys (Mastomys) natalensis: a model for gastric carcinoid formation.
por: Nilsson, O., et al.
Publicado: (1992)

Foreword: The Biological and Clinical Relevance of the Somatostatin Receptor
por: Modlin, Irvin M.
Publicado: (1997)

Verapamil and diarrhoea in the carcinoid syndrome--clinical and experimental observations on serotonin release.
por: Ahlman, H., et al.
Publicado: (1986)

Accumulation of natural killer cells after hepatic artery embolisation in the midgut carcinoid syndrome.
por: Wängberg, B., et al.
Publicado: (1995)

Microdosimetric analysis of (211)At in thyroid models for man, rat and mouse
por: Josefsson, Anders, et al.
Publicado: (2012)

Dosimetric analysis of (123)I, (125)I and (131)I in thyroid follicle models
por: Josefsson, Anders, et al.
Publicado: (2014)

Renal function affects absorbed dose to the kidneys and haematological toxicity during (177)Lu-DOTATATE treatment
por: Svensson, Johanna, et al.
Publicado: (2015)

NESP55, a novel chromogranin-like peptide, is expressed in endocrine tumours of the pancreas and adrenal medulla but not in ileal carcinoids
por: Jakobsen, A-M, et al.
Publicado: (2003)

A new method to estimate parameters of the growth model for metastatic tumours
por: Mehrara, Esmaeil, et al.
Publicado: (2013)

SAT-LB059 NET or NOT: Physiological Uptake in Pancreatic Head on Somatostatin Receptor Based Imaging
por: Jhawar, Sakshi, et al.
Publicado: (2019)

Localisation of somatostatin and somatostatin receptors in benign and malignant ovarian tumours
por: Hall, G H, et al.
Publicado: (2002)

Gemcitabine potentiates the anti-tumour effect of radiation on medullary thyroid cancer
por: Sandblom, Viktor, et al.
Publicado: (2019)

The biology and clinical relevance of somatostatin receptor scintigraphy in adrenal tumor management.
por: Kennedy, J. W., et al.
Publicado: (1997)

Prevalence of Germline Mutations in Patients with Pheochromocytoma or Abdominal Paraganglioma and Sporadic Presentation: A Population-Based Study in Western Sweden
por: Muth, Andreas, et al.
Publicado: (2012)

Transcriptional effects of (177)Lu-octreotate therapy using a priming treatment schedule on GOT1 tumor in nude mice
por: Spetz, Johan, et al.
Publicado: (2019)

Increased therapeutic effect on medullary thyroid cancer using a combination of radiation and tyrosine kinase inhibitors
por: Sandblom, Viktor, et al.
Publicado: (2020)

Distribution of somatostatin receptors in normal and neoplastic human tissues: recent advances and potential relevance.
por: Reubi, J. C., et al.
Publicado: (1997)

Thyroid Neoplasia
por: Hayes, Mark A.
Publicado: (1969)

Somatostatin Decorated Quantum Dots for Targeting of Somatostatin Receptors
por: Hafez Abdellatif, Ahmed Abdelfattah, et al.
Publicado: (2018)

Versatile Functions of Somatostatin and Somatostatin Receptors in the Gastrointestinal System
por: Shamsi, Bilal Haider, et al.
Publicado: (2021)

Epigenetic regulation of somatostatin and somatostatin receptors in neuroendocrine tumors and other types of cancer
por: Klomp, M.J., et al.
Publicado: (2020)

Pulmonary neuroendocrine tumours and somatostatin receptor status: an assessment of unlicensed use of somatostatin analogues in the clinical practice
por: Kiesewetter, B., et al.
Publicado: (2022)

Deconvolution of expression microarray data reveals (131)I-induced responses otherwise undetected in thyroid tissue
por: Langen, Britta, et al.
Publicado: (2018)

Incidental cardiac findings on somatostatin receptor PET/CT: What do they indicate and are they of clinical relevance?
por: Bobbio, Emanuele, et al.
Publicado: (2021)

Priming increases the anti-tumor effect and therapeutic window of (177)Lu-octreotate in nude mice bearing human small intestine neuroendocrine tumor GOT1
por: Dalmo, Johanna, et al.
Publicado: (2017)

Successful Primary Medical Therapy with Somatostatin Receptor Ligand in Acromegaly with Thyroid Cancer
por: Dharan, Shalini Sree, et al.
Publicado: (2017)

Exploration of Somatostatin Binding Mechanism to Somatostatin Receptor Subtype 4
por: Börzsei, Rita, et al.
Publicado: (2022)

Somatostatin receptor-directed molecular imaging for therapeutic decision-making in patients with medullary thyroid carcinoma
por: Serfling, Sebastian E., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_kvqcfii2d920ughqv89fejuhl4